FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510167417> ?p ?o ?g. }

• W2510167417 endingPage "4477" @default.
• W2510167417 startingPage "4468" @default.
• W2510167417 abstract "Only approximately 85% of patients with a clinical diagnosis complete androgen insensitivity syndrome and less than 30% with partial androgen insensitivity syndrome can be explained by inactivating mutations in the androgen receptor (AR) gene. The objective of the study was to clarify this discrepancy by in vitro determination of AR transcriptional activity in individuals with disorders of sex development (DSD) and male controls. Quantification of DHT-dependent transcriptional induction of the AR target gene apolipoprotein D (APOD) in cultured genital fibroblasts (GFs) (APOD assay) and next-generation sequencing of the complete coding and noncoding AR locus. The study was conducted at a university hospital endocrine research laboratory. GFs from 169 individuals were studied encompassing control males (n = 68), molecular defined DSD other than androgen insensitivity syndrome (AIS; n = 18), AR mutation-positive AIS (n = 37), and previously undiagnosed DSD including patients with a clinical suspicion of AIS (n = 46). There were no interventions. DHT-dependent APOD expression in cultured GF and AR mutation status in 169 individuals was measured. The APOD assay clearly separated control individuals (healthy males and molecular defined DSD patients other than AIS) from genetically proven AIS (cutoff < 2.3-fold APOD-induction; 100% sensitivity, 93.3% specificity, P < .0001). Of 46 DSD individuals with no AR mutation, 17 (37%) fell below the cutoff, indicating disrupted androgen signaling. AR mutation-positive AIS can be reliably identified by the APOD assay. Its combination with next-generation sequencing of the AR locus uncovered an AR mutation-negative, new class of androgen resistance, which we propose to name AIS type II. Our data support the existence of cellular components outside the AR affecting androgen signaling during sexual differentiation with high clinical relevance." @default.
• W2510167417 created "2016-09-16" @default.
• W2510167417 creator A5005005766 @default.
• W2510167417 creator A5006528004 @default.
• W2510167417 creator A5008080768 @default.
• W2510167417 creator A5008597202 @default.
• W2510167417 creator A5011920743 @default.
• W2510167417 creator A5018333266 @default.
• W2510167417 creator A5021366050 @default.
• W2510167417 creator A5024433492 @default.
• W2510167417 creator A5030831053 @default.
• W2510167417 creator A5036758531 @default.
• W2510167417 creator A5037046482 @default.
• W2510167417 creator A5040063505 @default.
• W2510167417 creator A5040553559 @default.
• W2510167417 creator A5042966612 @default.
• W2510167417 creator A5053330727 @default.
• W2510167417 creator A5054741975 @default.
• W2510167417 creator A5060503923 @default.
• W2510167417 creator A5065602571 @default.
• W2510167417 creator A5065761260 @default.
• W2510167417 creator A5068464247 @default.
• W2510167417 creator A5069511298 @default.
• W2510167417 creator A5074355590 @default.
• W2510167417 creator A5074658523 @default.
• W2510167417 creator A5076963435 @default.
• W2510167417 creator A5083937485 @default.
• W2510167417 date "2016-11-01" @default.
• W2510167417 modified "2023-10-17" @default.
• W2510167417 title "Identification of an <i>AR</i> Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity" @default.
• W2510167417 cites W1965283193 @default.
• W2510167417 cites W1971513564 @default.
• W2510167417 cites W1975861918 @default.
• W2510167417 cites W1976962315 @default.
• W2510167417 cites W1983017995 @default.
• W2510167417 cites W1989642228 @default.
• W2510167417 cites W2011046917 @default.
• W2510167417 cites W2017935470 @default.
• W2510167417 cites W2017977369 @default.
• W2510167417 cites W2024962654 @default.
• W2510167417 cites W2027075319 @default.
• W2510167417 cites W2032262710 @default.
• W2510167417 cites W2055655957 @default.
• W2510167417 cites W2057611301 @default.
• W2510167417 cites W2062263904 @default.
• W2510167417 cites W2066652469 @default.
• W2510167417 cites W2072768062 @default.
• W2510167417 cites W2080202166 @default.
• W2510167417 cites W2108564113 @default.
• W2510167417 cites W2133150634 @default.
• W2510167417 cites W2141198558 @default.
• W2510167417 cites W2144854612 @default.
• W2510167417 cites W2144908726 @default.
• W2510167417 cites W2155199697 @default.
• W2510167417 cites W2162361371 @default.
• W2510167417 cites W2164092182 @default.
• W2510167417 cites W2169878619 @default.
• W2510167417 cites W2171967408 @default.
• W2510167417 cites W2321220648 @default.
• W2510167417 cites W2343747384 @default.
• W2510167417 cites W2403659730 @default.
• W2510167417 cites W2092552234 @default.
• W2510167417 cites W248638898 @default.
• W2510167417 doi "https://doi.org/10.1210/jc.2016-1990" @default.
• W2510167417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5095254" @default.
• W2510167417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27583472" @default.
• W2510167417 hasPublicationYear "2016" @default.
• W2510167417 type Work @default.
• W2510167417 sameAs 2510167417 @default.
• W2510167417 citedByCount "61" @default.
• W2510167417 countsByYear W25101674172016 @default.
• W2510167417 countsByYear W25101674172017 @default.
• W2510167417 countsByYear W25101674172018 @default.
• W2510167417 countsByYear W25101674172019 @default.
• W2510167417 countsByYear W25101674172020 @default.
• W2510167417 countsByYear W25101674172021 @default.
• W2510167417 countsByYear W25101674172022 @default.
• W2510167417 countsByYear W25101674172023 @default.
• W2510167417 crossrefType "journal-article" @default.
• W2510167417 hasAuthorship W2510167417A5005005766 @default.
• W2510167417 hasAuthorship W2510167417A5006528004 @default.
• W2510167417 hasAuthorship W2510167417A5008080768 @default.
• W2510167417 hasAuthorship W2510167417A5008597202 @default.
• W2510167417 hasAuthorship W2510167417A5011920743 @default.
• W2510167417 hasAuthorship W2510167417A5018333266 @default.
• W2510167417 hasAuthorship W2510167417A5021366050 @default.
• W2510167417 hasAuthorship W2510167417A5024433492 @default.
• W2510167417 hasAuthorship W2510167417A5030831053 @default.
• W2510167417 hasAuthorship W2510167417A5036758531 @default.
• W2510167417 hasAuthorship W2510167417A5037046482 @default.
• W2510167417 hasAuthorship W2510167417A5040063505 @default.
• W2510167417 hasAuthorship W2510167417A5040553559 @default.
• W2510167417 hasAuthorship W2510167417A5042966612 @default.
• W2510167417 hasAuthorship W2510167417A5053330727 @default.
• W2510167417 hasAuthorship W2510167417A5054741975 @default.
• W2510167417 hasAuthorship W2510167417A5060503923 @default.
• W2510167417 hasAuthorship W2510167417A5065602571 @default.
• W2510167417 hasAuthorship W2510167417A5065761260 @default.

• next